When It Comes to Vaccinations, More Is More
(Bloomberg Opinion) -- Sins of commission and sins of omission are often treated differently, but it's not clear they should be. Most of us, for example, would never dream of killing another person. At the same time, about 160,000 people around the world die every day, often of preventable causes. Letting people die — a sin of omission — seems tolerable in a way that killing a person — a sin of commission — does not.
Philosophers such as Peter Singer have argued that people ought to take their obligations to the global poor far more seriously. Yet most people simply go about their lives, and even if they make major donations to charity, it's not half their incomes. For better or worse, common-sense morality leads most people to devote only a limited amount of attention to problems outside their own social circle.
But what about governments? It is an increasingly important question whether regulators and public officials should treat sins of commission and sins of omission in such an asymmetrical manner. As I understand the Food and Drug Administration and the Centers for Disease Control, they worry much more about sins of commission than about sins of omission.
The FDA, for instance, still has not approved the AstraZeneca vaccine, or outlined a clear path to approval, although it is approved in many other developed nations, including Canada, and the recent evidence on safety and efficacy is strongly positive, even for a single dose. The result of the FDA's sluggishness, quite simply, is thousands of additional American deaths, for no good reason. Yet Americans are not taking to the streets to demand the AstraZeneca vaccine.
How U.S. public officials and regulators talk about vaccination also reflects an asymmetric treatment of errors of commission and omission. The general message is that even after Americans are vaccinated, they will still have to wear masks, refrain from visiting their loved ones, and so on. And to be sure, even twice-vaccinated people face some risk of contracting Covid or transmitting it. Public health officials are afraid if they tell people to relax, some Americans will take more risk, and more deaths will result.
That is a legitimate concern — but there are risks in both directions. If getting vaccinated is not seen as a significant life improvement, people will be less likely to get vaccinated. So the better message, from both an individual and public-health standpoint, is that getting vaccinated will lead to fun consequences.
To be clear, public health officials are encouraging additional vaccinations. But they don't seem to realize how much their own ostensibly “careful” rhetoric makes vaccination sound unappealing. “Not talking up the vaccines” is a sin of omission, not a sin of commission, and so it is tolerated and is not a major issue for public debate.
Should public officials be allowed, indeed encouraged, to treat sins of commission and omission so differently, as private citizens (myself included) typically do?
I live near Arlington National Cemetery, where approximately 400,000 veterans (and family members) are buried. I suspect they would not care so much whether their deaths were the result of errors of commission or omission. Did a commanding general order a hill to be charged that should have been left alone? Or did he make the mistake of not charging a hill that could have been taken?
Most citizens care about the total number of military casualties from a battle and are only modestly concerned about the details of the mistakes that caused them. That seems like the right and rational attitude. Perhaps it is also the correct attitude for the war against the coronavirus — that is, an overriding concern with casualties and outcomes, regardless of the kind of error that led to them.
The philosopher Robert E. Goodin has argued that individuals cannot help but give priority to their own selfish interests. But governments have overarching responsibilities to all citizens — and when it comes to life-and-death decisions, the outcome rather than the process should be paramount. Governments thus should follow a broader, more inclusive moral code than should citizens. This will push them closer to utilitarianism, and an equal concern for all.
In fact, the very act of failing to discard the traditional distinction between errors of commission and omission is itself an error of omission, and a very serious one.
This column does not necessarily reflect the opinion of the editorial board or Bloomberg LP and its owners.
Tyler Cowen is a Bloomberg Opinion columnist. He is a professor of economics at George Mason University and writes for the blog Marginal Revolution. His books include "Big Business: A Love Letter to an American Anti-Hero."
©2021 Bloomberg L.P.
-
Navigating Energy Crossroads: S Jaishankar's Call For Diversified Supply Chains At G20 Ministerial Meeting
As geopolitical fault lines continue to test maritime trade routes and commodity flows, Jaishankar's message remains pertinent: true economic resilience requires open markets, protected transit lines, and a genuine commitment to multilateral cooperation rather than coercion.
-
Indians Are Travelling, But Not Every Journey Is A Holiday | The Week In Whys
Pilgrims, patients and working women are the real travellers, and the system hasn't quite caught up with them.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.